Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-250-0 | CAS number: 72619-32-0 HALOXYFOP R-(+)-ME HERBICIDAL CHEMICAL
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Additional documentation provided in IUCLID assesment reports (Chapter 13) supports the read across approach
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Additional documentation provided in IUCLID assesment reports (Chapter 13) supports the read across approach
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 1 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- maternal abnormalities
- Key result
- Remarks on result:
- other: Oral administration of the test substance was not teratogenic to rats at doses up to 7.5 mg/kg bw/day.
- Key result
- Developmental effects observed:
- no
- Conclusions:
- Rat NOEL: 1.0 mg/kg/day (maternal effects)
Oral administration of the test substance was not teratogenic to rats at doses up to 7.5 mg/kg bw/day. - Executive summary:
The objective of this study was to evaluate the embryotoxic and teratogenic potential of repeated oral administration of the test substance during organogenesis in rats. Bred rats were given 0, 0.1, 1.0, or 7.5 mg test substance /kg/day by gavage on days 6 through 15 of gestation.
Slight maternal toxicity was observed in the 7.5 mg/kg group as evidenced by decreased weight gain and food consumption early in gestation. No evidence of embryotoxicity or teratogenicity was observed in rats.
In conclusion, oral administration of the test substance during organogenesis was not teratogenic in rats at dose levels as high as 7.5 mg/kg/day.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Groups of at least 30 bred rats were given the test substance by gavage on days 6 through 15 of gestation at a level of 0.1, 1.0 and 7.5 mg/kg of test substance/day. Test animals were sacrificed by carbon dioxide inhalation on gestation day 21 and observed for alterations.
- GLP compliance:
- yes
Test material
- Reference substance name:
- (2S)-2-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]propanoic acid
- Cas Number:
- 95977-27-8
- Molecular formula:
- C15H11ClF3NO4
- IUPAC Name:
- (2S)-2-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]propanoic acid
Constituent 1
- Specific details on test material used for the study:
- DOWCO 453 acid
Lot # AGR 192975
Purity: 99.7%
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Portage, Michigan
- Weight at breeding: Approximately 175-220 g
- Diet: Certified Laboratory animal Chow, ad libitum
- Water: Muncipal tap water, ad libitum
- Acclimation period: At least 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature: Approximately 22°C
- Humidity: Approximately 50%
- Photoperiod: 12 hrs dark /12 hrs light
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- deionized distilled
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
- The sodium salt of test substance was prepared in deionized-distilled water by adding 1.0 N sodium hydroxide solution to dissolve the acid. The sample was back titrated with hydrochloric acid solution to a pH between 6 and 7. Solutions of test substance-sodium salt were prepared such that a dose volume of 4 mL/kg of body weight/day yielded the appropriate acid equivalent for each dose level. Fresh solutions of test substance-sodium salt were prepared as required based upon the previously reported 14 day stability data. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The mean analytical concentration of the dosing solutions used was 93-95% of the target concentration.
- Details on mating procedure:
- - Impregnation procedure: Adult virgin female rats were bred to adult males (one female to one male) from the same strain. The day sperm were found in a vaginal smear was considered day zero of gestation.
- Duration of treatment / exposure:
- GD6-GD15
- Frequency of treatment:
- Daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.1 mg/kg bw/day
- Dose / conc.:
- 1 mg/kg bw/day
- Dose / conc.:
- 7.5 mg/kg bw/day
- No. of animals per sex per dose:
- 30, 31, 31 and 30 dams in the control, 0.1, 1.0 and 7.5 mg/kg/day groups, respectively
- Control animals:
- yes, concurrent vehicle
Examinations
- Maternal examinations:
- OBSERVATIONS
- Time schedule: Daily
BODY WEIGHT
- Time schedule for examinations: Body weights were recorded on gestation days 6 through 16 and on day 21 of gestation
POST-MORTEM EXAMINATIONS
- Sacrifice on gestation day # 21 - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No
- Number and position of fetuses: Yes
- Number of live and dead fetus: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Sex, body weight and crown-rump length of each fetus: Yes - Fetal examinations:
- - External examinations: Yes: [all per litter]
- Soft tissue examinations: Yes: [half per litter]
- Skeletal examinations: Yes: [all per litter] - Statistics:
- Maternal body weights, food and water consumption, absolute and relative organ weights, and fetal weight and length were evaluated by Bartlett's test for equality of variances. Based upon the outcome of Bartlett's test, a parametric or nonparametric analysis of variance (ANOVA) was performed. If the ANOVA was significant, a Dunnett's test or the Wilcoxon Rank-Sum test with Bonferroni's correction was performed. Corpora lutea, implantations, and litter size were analyzed by the Wilcoxon Rank-Sum test with Bonferroni's correction. For food consumption, statistical outliers were identified by a sequential method and excluded from analysis. Pregnancy rate was analyzed by the Fisher Exact Probability test. Evaluation of the neonatal sex ratio was done using the binomial distribution test. The frequency of alterations, resorptions, and other incidence data were analyzed by the Wilcoxon test, using the litter as the experimental unit.
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- no treatment-related effects on general appearance or demeanor were observed among bred rats given 0, 0.1, 1.0, or 7.5 mg/kg/day on days 6 through 15 of gestation.
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Decreases in body weight gain during days 6 through 8 of gestation, was observed in the 7.5 mg/kg/day group
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- Decreases in food consumption during days 6 through 8 of gestation, was observed in the 7.5 mg/kg/day group
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Description (incidence and severity):
- Water consumption in the top dose group was increased on days 12 through 20 of gestation.
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- Only liver weights were observed; Absolute and relative liver weights among the treated groups were comparable to controls
Maternal developmental toxicity
- Pre- and post-implantation loss:
- no effects observed
- Total litter losses by resorption:
- no effects observed
- Description (incidence and severity):
- The incidence of implantations undergoing resorption among the treatment groups was comparable to the control group indicating that the test substance was not embryolethal in rats.
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 1 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- maternal abnormalities
Results (fetuses)
- Fetal body weight changes:
- no effects observed
- Changes in sex ratio:
- no effects observed
- Changes in litter size and weights:
- no effects observed
- External malformations:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The incidence of individual malformations was not significantly increased for any of the treated groups compared to controls
- Skeletal malformations:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No skeletal malformations were observed in any group including controls. A significant increase in the incidence of delayed ossification of the centra of the thoracic vertebrae was observed in the 7.5 mg/kg/day group. A slight increase in the incidence of unfused thoracic centra was also observed in this group. The deffects may be indicative of a slight fetotoxic effect which is probably secondary to the slight maternal toxicity observed in this group.
- Visceral malformations:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The incidence of individual malformations was not significantly increased for any of the treated groups compared to controls
Effect levels (fetuses)
- Key result
- Remarks on result:
- other: Oral administration of the test substance was not teratogenic to rats at doses up to 7.5 mg/kg bw/day.
Overall developmental toxicity
- Key result
- Developmental effects observed:
- no
Any other information on results incl. tables
Table 1: Body weights and weight changes (g) of pregnant rats (significant observations)
Gestation day |
0 mg/kg/day |
0.1 mg/kg/day |
1.0 mg/kg/day |
7.5 mg/kg/day |
16 |
236±13 |
231±12 |
232±10 |
228±14* |
21 |
274±19 |
261 ±20 |
267±19 |
260±23* |
6-8 |
6±3 |
5±4 |
6±3 |
4±3* |
*Statistically different from the control value by Dunnett's test,α=0.05.
Table 2: Food consumption (g/rat/day) of pregnant rats (significant observations)
Gestation day |
0 mg/kg/day |
0.1 mg/kg/day |
1.0 mg/kg/day |
7.5 mg/kg/day |
6-8 |
14±1 |
14±1 |
14±1 |
13±1* |
*Statistically different from the control value by Dunnett's test,α=0.05.
Table 3: Water consumption (g/rat/day) of pregnant rats (significant observations)
Gestation day |
0 mg/kg/day |
0.1 mg/kg/day |
1.0 mg/kg/day |
7.5 mg/kg/day |
12-14 |
27±5 |
28±4 |
28±3 |
32±10* |
15-17 |
34±4 |
33±4 |
33±4 |
40±14* |
18-20 |
28±3 |
29±4 |
30±3 |
33±5* |
*Statistically different from the control value by Dunnett's test,α=0.05.
Table 4: Incidence of Fetal Alterations Among Litters of Pregnant Rats (significant observations)
Skeletal observations |
0 mg/kg/day |
0.1 mg/kg/day |
1.0 mg/kg/day |
7.5 mg/kg/day |
|
Delayed ossification of thoracic centra |
F |
1(2) |
2(4) |
1(2) |
6 (11)* |
L |
8(2) |
12(3) |
4(1) |
33 (8)* |
Number Fetuses (Number Litters) Examined
*Statistically different from the control value by a modified Wilcoxon test,α=0.05.
Applicant's summary and conclusion
- Conclusions:
- Rat NOEL: 1.0 mg/kg/day (maternal effects)
Oral administration of the test substance was not teratogenic to rats at doses up to 7.5 mg/kg bw/day. - Executive summary:
The objective of this study was to evaluate the embryotoxic and teratogenic potential of repeated oral administration of the test substance during organogenesis in rats. Bred rats were given 0, 0.1, 1.0, or 7.5 mg test substance/kg/day by gavage on days 6 through 15 of gestation.
Slight maternal toxicity was observed in the 7.5 mg/kg group as evidenced by decreased weight gain and food consumption early in gestation. No evidence of embryotoxicity or teratogenicity was observed in rats.
In conclusion, oral administration of the test substance during organogenesis was not teratogenic in rats at dose levels as high as 7.5 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.